T2 Biosystems IncのEBITDA
T2 Biosystems IncのEBITDAは何ですか。
T2 Biosystems IncのEBITDAは-42.13$です。
EBITDAの定義は何ですか。
EBITDA は、会社の営業成績を表す利息、税金、減価償却費および償却費を控除する前の利益です。
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
NASDAQのセクタHealth CareにおけるEBITDAの企業と比べるT2 Biosystems Inc
T2 Biosystems Incは何をしますか。
t2 biosystems is developing innovative diagnostic products to improve patient health. with two fda-cleared products targeting sepsis – the cause of one out of two hospital deaths - and a range of additional products in development, t2 biosystems is an emerging leader in the field of in vitro diagnostics. our initial development efforts target sepsis, hemostasis, bacteria and lyme disease, which are areas of significant unmet medical need. the company is utilizing its proprietary t2 magnetic resonance platform, or t2mr®, to develop a broad set of applications aimed at lowering mortality rates, improving patient outcomes and reducing the cost of healthcare by helping medical professionals make targeted treatment decisions earlier. at t2 biosystems, we know that our passion to advance the medical diagnostic landscape relies on our ability to attract and retain the very best people in the world – and to encourage them to flourish. we invite you to apply for one of our open positions at www
T2 Biosystems Incと類似のebitda
- Elmo SoftwareのEBITDAは-42.33AUD$です。
- Elmo SoftwareのEBITDAは-42.33AUD$です。
- CyberArk Software LtdのEBITDAは-42.29$です。
- Modern Healthcare TechnologyのEBITDAは-42.23HKD$です。
- PAVmedのEBITDAは-42.20$です。
- China Bozza DevelopmentのEBITDAは-42.15¥です。
- T2 Biosystems IncのEBITDAは-42.13$です。
- Cardiol TherapeuticsのEBITDAは-42.12CAD$です。
- China SilverのEBITDAは-41.98¥です。
- CulturecomのEBITDAは-41.93HKD$です。
- 3D SystemsのEBITDAは-41.72$です。
- 3D SystemsのEBITDAは-41.72$です。
- SterlingのEBITDAは-41.72HKD$です。